Brokers Issue Forecasts for REGN FY2025 Earnings
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Regeneron Pharmaceuticals in a research report issued on Tuesday, April 22nd. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will earn $26.38 per share for the year. Cantor Fitzgerald currently has […]
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) – Equities research analysts at Cantor Fitzgerald issued their FY2025 earnings per share estimates for Regeneron Pharmaceuticals in a research report issued on Tuesday, April 22nd. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will earn $26.38 per share for the year. Cantor Fitzgerald currently has […]
